Introduction
============

Retinitis pigmentosa (RP) is the most common form of inherited retinopathy, with an incidence of 1 in 4,000. RP is a clinically and genetically heterogeneous group of retinal dystrophies, characterized by progressive degeneration of the photoreceptors. Clinical features include progressive night blindness, constriction and gradual loss of the peripheral visual field, and eventual loss of visual acuity \[[@r1],[@r2]\]. RP can be inherited as an autosomal recessive (arRP), an autosomal dominant (adRP), or an X-linked recessive (xlRP) pattern \[[@r1],[@r2]\]. To date, at least 23 causative genes have been identified for adRP, 35 for arRP, and two for xlRP ([RetNet](http://www.sphuth.tmc.edu/retinet%20/sum-dis.htm)).

The PRP31 premessenger ribonucleic acid (pre-mRNA) processing factor 31 homolog (*PRPF31*) gene located in chromosome 19q13.42 was identified as the causative gene of adRP at the RP11 locus \[[@r3]\]. This gene encompasses 14 exons and codes 499 amino acids that ubiquitously express a pre-mRNA splicing factor. To date, 62 mutations of the *PRPF31* gene have been recorded in the [Human Genome Mutation Database](http://www.hgmd.cf.ac.uk/ac/all.php) (HGMD), and almost 90% of them are splicing mutations (26%), deletions (39%), nonsense mutations (10%), insertions (8%), and indels (6%). Due to exon skipping and premature stop codons, the majority of mutations result in truncated proteins; therefore, haploinsufficiency was suggested as a mechanism of RP11 evolvement \[[@r3]-[@r13]\].

A unique feature of the *PRPF31* mutations is bimodal expressivity. Individuals carrying mutations of the *PRPF31* gene can either present severe phenotypes at an early age or be completely asymptomatic individuals. This "all or none" form of incomplete penetrance represents the existence of two different wild-type *PRPF31* alleles \[[@r14]-[@r16]\]. Consequently, an individual carrying a mutant allele and a high expressivity wild-type *PRPF31* allele would not display RP symptoms \[[@r14]-[@r16]\].

The CCR4-NOT transcription complex, subunit 3 (*CNOT3*) gene has recently been identified as the main modifier gene responsible for penetrance of *PRPF31* mutations. In asymptomatic individuals, the *CNOT3* gene was expressed at a low level, allowing high expression of the wild-type *PRPF31* \[[@r17]\]. The C allele of single nucleotide polymorphism (SNP) rs4806718 in the intronic region of the *CNOT3* gene is associated with the affected status while the T allele is associated with asymptomatic status \[[@r17]\].

In this study, we investigated two Chinese families with adRP. After linkage and haplotyping analysis, the disease-causing gene was mapped to the RP11 region. We identified one novel deletion in one family and one novel complex insertion-deletion (indel) of the *PRPF31* gene in the other family. One family with the complex indel showed complete disease penetrance, whereas the other family with the deletion contained an asymptomatic disease gene carrier.

Methods
=======

Participants and deoxyribonucleic acid samples
----------------------------------------------

Thirty individuals including 16 males and 14 females with age range from 5 to 71 years old from two families with RP patients were recruited on a voluntary basis from Beijing Tongren Hospital. Each participant underwent careful ophthalmologic examinations, including best-corrected visual acuity testing using E decimal charts, slit-lamp biomicroscopy, and fundus examination with dilated pupils. Some of the patients had visual field testing and electroretinogram (ERG) examination. ERG was performed (GT-2008V-I ERG system, Guo Te Medical Equipment, Chongqing, China) using corneal ERGjet contact lens electrodes, according to International Society for Clinical Electrophysiology of Vision (ISCEV) standards \[[@r18]\]. The diagnosis of RP was based on the presence of night blindness, typical fundus findings (characteristic retinal pigmentation, vessel attenuation, and waxy pallor of the optic disc), different extent of loss of peripheral visual field, and abnormal ERG. This study adhered to the tenets of the Declaration of Helsinki for research involving human subjects. The Beijing Tongren Hospital Joint Committee on Clinical Investigation approved the study, and informed consent was obtained from all patients. Peripheral blood samples were collected from all the participants by venipuncture in heparinized collecting tubes and stored at 4 °C for less than one week. Genomic DNA was extracted from peripheral blood leukocytes using a genomic DNA extraction and purification kit (Vigorous Whole Blood Genomic DNA extraction Kit, Vigorous Beijing, China), according to the manufacturer's protocol.

Genotyping and linkage analysis
-------------------------------

Linkage analyses were performed with 41 microsatellite markers flanking each of the known adRP loci in the two families (Appendix 1). Short tandem repeat (STR) loci were amplified from family member DNA with fluorescent PCR primers and DNA polymerase in standard multiplex reaction conditions. PCR products were pooled and diluted in water and run on an ABI Prism 373A DNA sequencer (Applied Biosystems Inc., Foster City, CA). Two-point linkage analyses were performed with the [LINKAGE](http://linkage.rockefeller.edu/soft) program package 5.2, using a dominant model with 100% penetrance for family RP24 and 83.3% (the ratio between symptomatic individuals and all disease-gene carriers) for family RP106.

Mutation screening of the PRP31 premessenger ribonucleic acid processing factor 31 homolog gene
-----------------------------------------------------------------------------------------------

Mutation screening was performed in the two families using direct DNA sequence analysis. The coding regions and the exon--intron boundaries of the *PRPF31* gene were amplified with PCR in the patients of the two families. The pairs of primers were used according to a previously published article \[[@r4]\] ([Table 1](#t1){ref-type="table"}). PCR assays were performed using standard reaction mixtures, and purified PCR products were directly sequenced on an ABI Prism 373A DNA sequencer. Nucleotide sequences were compared with the published cDNA sequence of the *PRPF31* gene (GenBank [NM_015629](http://www.ncbi.nlm.nih.gov/nuccore/NM_015629)). For the *PRPF31* gene, cDNA numbering +1 corresponds to A in the ATG translation initiation codon in PRPF31.

###### Primers used in sequencing of the PRPF31 gene and allele-specific PCR analysis.

  Exon/mutation site or SNP   Primer sequence (5\'-3\')     TM (°C)
  --------------------------- ----------------------------- ---------
  2,3                         F: GTCGGGGCAAGTTTTTAGGG       64
                              R: GAGATGGGGAGGGGCACAGAGT     
  4                           F: CCGAGAGGGGGTAGGGATTTAGAT   64
                              R: AGGCCAGTGGGGAAGGGAGAGG     
  5                           F: TTAGGGCCAACCAGCAGAGTC      64
                              R: GAGGGGGTCCGAGATGAGC        
  6,7                         F: GTTCCCGAGCCTCCCCTATCTTCT   64
                              R: CGCTCCAGCTCCTCCTCCGACAG    
  8                           F: CCGGCGGCCTGACCAACC         64
                              R: GGGAGGGGCCATGACGCAGTG      
  9                           F: GCGCGGTTGCTTTGCTGTTA       64
                              R: ACTGCCTCCGCCTTGGTAG        
  10,11                       F: GTGGCGGTGAGGCAGCATTAGGTG   55
                              R: CTGGCTGGCTGTGGGGTTGAGGA    
  12,13                       F: GGGCCTGGTCGCTGA            64
                              R: GGGGAGGTACCTGGAGTGG        
  14                          F: GGTCACAGTTGGGGCCTTCTCCTC   64
                              R: TACTGGGCGGTGATCTCGGTCCTG   
  13/p.G405fs+7X              F: AAGTCGGGCAGTGG**C**        60
  PRPF31-3A2R                 R: AGGTTCACGCCATTCTC          
  INS-R                       R: TAGTCTCATGGACAGGTCTAGCCG   60
  rs4806718                   F: GCCCTCTCATCCTCCCACTT       58
                              R: TGCTGAGTGCTGGGACCT         

Abbreviations: F,forward; R:reverse; Primer sequences with lower case indicate modified nucleotides in order to specifically amplify the mutant sequence; red,mutation-specific nucleotide.

Real-time quantitative polymerase chain reaction and breakpoint analysis
------------------------------------------------------------------------

Large deletions were detected using real-time quantitative PCR (RQ-PCR), as described in our previous study, on samples from one affected member of family RP24 with a panel of pairs of primers around the *PRPF31* gene ([Table 2](#t2){ref-type="table"}) \[[@r19]\]. The RQ-PCR reactions were performed on the Rotor-Gene 6000 (Corbett Research, Mortlake, NSW, Australia) in a final volume of 10 µl, containing 300 nM primers and 1 µl (100 ng) genomic DNA, using the EvaGreen PCR MasterMix (Bio-Rad, Hercules, CA). Each assay was performed in triplicate. The relative quantitation (RQ) of the target gene was accomplished using RQ manager software (Bio-Rad) and was calculated with the 2^-ddCt^ method \[[@r19]\]. All experimental samples were normalized using the human glyceraldehyde-3-phosphate dehydrogenase gene as an internal control. Threshold values were set at 0.8--1.3 for normal, 0.45--0.74 for deletions, and 1.6--1.8 for duplication. Experiments were replicated at least twice if a deletion was suspected.

###### Primers informations and results of the real-time quantitative PCR

  Gene/SNP     Physical position     Primer sequences (Forward 5′-3′)   Primer sequences (Reverse 5′-3′)   RQ results\*
  ------------ --------------------- ---------------------------------- ---------------------------------- --------------
  OSCAR        54,597,933-54604148                                                                         
  REN91524     54,602,623-54602867   GTGCTGGGATTACAGACGTTGG             ACCAGGAACTTCTGAGGCAGAG             1.2
  REN91525     54,602,851-54603100   CCTCAGAAGTTCCTGGTCTTCAGT           AAAGAAACTAGTCCCTCAACCTCCT          1.18
  REN91526     54,602,890-54603139   CCACTAAGGGGAATGAGAAAAGAA           AGAGTGAGAGTCTGCCTCAGACAA           0.4
  REN91528     54,603,636-54603883   CCAGGGAACAATGATCGTAGAGTT           AGAGAACACAGATTCCCGAAAGAG           0.51
  REN91537     54,605,887-54606047   AGGCTGAGACTAAGGAGATTCCAC           CTGGGAGTTGTGGTCCCTATG              0.38
  NDUFA3       54,606,160-54610280                                                                         
  Exon2        54,606,422-54606583   GTGGCACGAGAGGGTTAGAG               GCGATAGGGCTTTAGGGGTA               0.44
  REN91541     54,606,723-54606962   GTTCTCAACCCTGCTTATGCCTTA           CAGGAACTCCGGTGCTAATTAAAG           0.48
  REN91551     54,609,843-54610094   CTTGGTCTCCATCTTCTCAGGTTT           TGAGACCAGCACGTCTCCAG               0.54
  TFPT         54,610,320-54619055                                                                         
  REN91555     54,610,701-54610956   ACTTGCCAACCAAGCCTAACAT             GGAGGAAAGCTGGAAGAACATCT            0.48
  REN91573     54,614,408-54614644   AGGAGGTGCGACTTTAGTTACGAC           CCGGAACTCAGGTCTTTCTGAC             0.5
  PFPF31       54,618,790-54635150                                                                         
  Exon1        54,619,151            ACGTGAGTCCCTTTCCTCCT               TCACCGATGACGTCTCACTC               0.47
  Exon2        54,621,659-54621835   TGAGCTCTTAGCTGATCTCGAA             CATAGCTTGGCGATGGTCTT               0.38
  Intron3      54,622,743-54622989   CAGAGCAAGACTCCGTCTCA               TTGCAATGAGCCAAGAACAC               1.22
  Intron3--1   54,623,071-54623280   TCACCATGTTGACCAGGCTA               AAGCAGTGAGTCTCCCGAAA               1.05
  Exon6        54,626,833-54627082   GAGCTGGGCAACAGCCTGGA               CCCGGGTGCCTGGTGTG                  1.25
  Exon12       54,632,417-54632529   TACCAGGAGGACCTGGGATT               GCAGCGTCTTGGAGATCCT                0.86
  Exon14       54,634,733-54633836   GGAGATTGTGAACCCACAGG               ACTCTTCTCGCCCTTGACCT               0.99

Abbreviations: RQ,relative quantity; \*, mean value of three times.

The breakpoint region was defined using long-range PCR (Vigorous Biotechnology, Beijing, China) with primers adjacent to the deleted regions and additional nested primers 91925F and PRPF31-3A2R ([Table 1](#t1){ref-type="table"} and [Table 2](#t2){ref-type="table"} ). PCR products were purified and sequenced.

Allele-specific polymerase chain reaction analysis
--------------------------------------------------

The variation found in the sequencing was confirmed with allele-specific PCR (AS-PCR) analysis of the available family members and 100 normal controls \[[@r20]\]. An allele-specific forward primer in the exon 13 of the *PRPF31* gene was designed ([Table 1](#t1){ref-type="table"}). AS-PCR analysis was performed for the genomic DNA arrangement with the 91,525 forward primer and INS-R reversed primer ([Table 1](#t1){ref-type="table"}).

Single nucleotide polymorphism genotype
---------------------------------------

SNP [rs3760698](http://www.ncbi.nlm.nih.gov/snp/?term=rs3760698) located in the deletion region was sequenced using RQ-PCR primers in family RP24. *CNOT3* [rs4806718](http://www.ncbi.nlm.nih.gov/snp/?term=rs4806718) alleles were sequenced with primers ([Table 1](#t1){ref-type="table"}) in the two families.

Results
=======

Clinical findings
-----------------

Thirty individuals at risk for dominantly inherited RP in two Chinese families (RP24 and RP106) were examined ([Figure 1](#f1){ref-type="fig"}). Eight individuals in family RP24 and five members in family RP106 were diagnosed with RP ([Table 3](#t3){ref-type="table"}). All patients had experienced night blindness since early childhood and exhibited characteristic RP fundus appearance including atrophic retinal pigment epithelial (RPE) changes with bone spicule-like pigmentation ([Figure 2A,C,G](#f2){ref-type="fig"}). The patients who were over 30 years old usually developed secondary cataract ([Figure 2B,D](#f2){ref-type="fig"}). ERG testing of the patients showed undetectable rod and cone responses ([Figure 2H](#f2){ref-type="fig"}). An asymptomatic individual III:6 (a 37-year-old man with best corrected visual acuity of 1.0 in both eyes and a normal visual field) was identified in family RP106. His fundi were normal, and his ERG revealed normal rod and cone cell function ([Figure 2E,F](#f2){ref-type="fig"}).

![Family structure and haplotype analysis of two Chinese families with retinitis pigmentosa. Pedigree and haplotype analysis of family RP24 showed "loss of heterozygous" segregation with single nucleotide polymorphism (SNP) [rs3760698](http://www.ncbi.nlm.nih.gov/snp/?term=rs3760698) (red x). \#, 1 indicates the wild-type allele; 2 represents the mutant allele. All markers and SNPs are located on chromosome 19, listed in descending order from the centromeric end.](mv-v19-2426-f1){#f1}

###### The clinical features of patients of the two families.

  Familial number   Patient number   Age   Onset age of NB   BCV (OD/OS)   Cataract   Fundus apperence\*   Visual Field                      ERG            PRPF31 mutation
  ----------------- ---------------- ----- ----------------- ------------- ---------- -------------------- --------------------------------- -------------- -----------------
  RP24              III-1            71    C                 NLP/NLP       YES        NA                   NA                                NA             INDEL
                    IV-2             41    C                 0.2/0.3       YES        YES                  Constriction,central 20 degrees   Undetectable   INDEL
                    III-3            59    C                 HM/HM         YES        YES                  Constriction,central 10 degrees   Undetectable   INDEL
                    IV-4             34    C                 0.6/0.5       NO         YES                  Constriction,central 30 degrees   Undetectable   INDEL
                    IV-5             22    C                 0.7/0.8       NO         YES                  Constriction,central 30 degrees   Undetectable   INDEL
                    III-5            54    C                 HM/HM         YES        YES                  Constriction,central 15 degrees   NA             INDEL
                    IV-6             29    C                 0.4/0.1       YES        YES                  Constriction,central 20 degrees   NA             INDEL
                    III-6            49    C                 0.1/0.1       YES        YES                  Constriction,central 15 degrees   NA             INDEL
  RP106             II-1             64    C                 0.1/0.2       YES        YES                  NA                                NA             p.G405fs+7X
                    III-1            40    C                 0.2/0.01      YES        YES                  Constriction,central 20 degrees   Undetectable   p.G405fs+7X
                    III-3            32    C                 0.4/0.3       YES        YES                  Constriction,central 30 degrees   Undetectable   p.G405fs+7X
                    II-3             60    C                 0.1/0.1       YES        YES                  NA                                NA             p.G405fs+7X
                    III-6            33    NO                1.2/1.2       NO         NO                   Normal                            Normal         p.G405fs+7X
                    IV-3             9     C                 0.8/0.8       NO         YES                  NA                                Undetectable   p.G405fs+7X

Abbreviations:C,childhood; NB, night blindness; BCV, best corrected vision;OD,right eye; OS,left eye ;HM,hand move; NLP,no light peception; NA, unavailable,\*,intraretinal bone spicule pigments in four quadrants.

![Ophthalmological findings in patients from the two families. **A**: The fundus appearance of the right eye of patient III:3 in family RP24 shows atrophic retinal pigment epithelial changes, attenuation of the retinal vessels, and irregular pigment clumps in the peripheral retina. **B**: A slit-lamp photograph of the same eye showed dense white opacities located in the central zone of the lens. **C**: The fundus appearance of the right eye of patient III:1 in family RP106 shows atrophic retinal pigment epithelial changes, attenuation of the retinal vessels, and irregular pigment clumps in the peripheral retina. **D**: A photograph of the anterior segment of the same eye shows the opacities in the central zone of the lens. **E**: Fundus appearance of the right eye of individual III:6 from family RP106 displays a normal appearance. **F**: Electroretinography (ERG) shows normal rod and cone cell responses. **G**: The fundus appearance of the right eye of patient IV:3 (daughter of individual III:6) presents atrophic retinal pigment epithelial changes. **H**: The ERG shows extinguished rod and cone cell responses.](mv-v19-2426-f2){#f2}

Genotyping results
------------------

Two families were genotyped with 41 polymorphic markers around the known adRP loci. The mapping results excluded the other known adRP loci (or the results were not informative) with the exception of the *PRPF31* gene. The marker results for D19S927 and D19S926 were fully informative for linkage for family RP24, with two-point linkage odd disequilibrium scores of 3.48 (θ=0) and 3.55 (θ=0), respectively. For family RP106, the two-point limit of detection score for D19S571 was 3.21 (θ=0) with penetrance 0.83. Individual III:6 also carried the disease allele ([Figure 1](#f1){ref-type="fig"}).

Mutation analysis
-----------------

After we sequenced the *PRPF31* gene, we identified one novel heterozygous small deletion c.1215delG (p.G405fs+7X) in family RP106 ([Figure 3](#f3){ref-type="fig"}). AS-PCR analyses showed that the novel deletion cosegregated with the RP phenotype in family RP106, and was not detected in 100 normal controls ([Figure 3](#f3){ref-type="fig"}). We did not observe any obvious disease-causing mutation in family RP24. Linkage analysis for markers for *PRPF31* showed evidence of linkage; therefore, we considered detecting a large deletion around the *PRPF31* region in family RP24 using several real-time quantitative PCR tests. We identified a deletion of at least 19 kb involving part of the *PRPF31* and three upstream genes ([Table 2](#t2){ref-type="table"}).

![Deoxyribonucleic acid sequence chromatograms and allele-specific polymerase chain reaction analysis on the mutations detected in family RP106. **A**: The heterozygote sequence (sense strand) shows one-base-deletion c.1215delG (p.G405fs+7X) in patient III:1. **B**: The sequence shows the corresponding wild- type sequence. **C**: Allele-specific polymerase chain reaction (AS-PCR) analysis shows the amplified products of the mutation allele (382 bp) cosegregating with patients in this family. The fragments (830 bp), which are the parts of exon 3 of the myocilin (*MYOC*) gene, were used as the internal control in the AS-PCR analysis.](mv-v19-2426-f3){#f3}

The RQ-PCR results ([Table 2](#t2){ref-type="table"}) revealed a normal ratio for REN91525 and intron 3 of the *PRPF31* gene; therefore, we applied nested PCR amplifications with two pairs of primers and obtained a PCR fragment of over 700 bp. Sequencing of this product revealed a complex insertion-deletion (indel): a deletion of 19,517 nucleotides and an insertion of about 220 nucleotides. The deletion encompasses exon 1 of osteoclast associated immunoglobulin-like receptor (*OSCAR*), NADH dehydrogenase \[ubiquinone\] 1 alpha subcomplex 3 (*NDUFA3*), TCF3 \[E2A\] fusion partner (*TFPT*), and exon 1--3 of the *PRPF31* gene ([Figure 4](#f4){ref-type="fig"}). One breakpoint resides within an AluSx repeat in intron 1 of the *OSCAR* gene, and the other one is located in an AluY repeat in intron 3 of the *PRPF31* gene. The origin of the 220 bp insertion appears to be around the *OSCAR* gene, which is located 25 kb 5′ to the *PRPF31* gene. All patients in family RP24 showed "loss of heterozygosis" at [rs3760698](http://www.ncbi.nlm.nih.gov/snp/?term=rs3760698), which is located in the genomic DNA arrangement region ([Figure 1](#f1){ref-type="fig"}). Sequencing of CNOT3 [rs4806718](http://www.ncbi.nlm.nih.gov/snp/?term=rs4806718) revealed three patients (III:3, III:5, and III:7) in family RP24 who harbored C/T alleles, whereas the remaining nine patients and the asymptomatic individual carried homozygous T alleles ([Figure 1](#f1){ref-type="fig"}).

![Genomic rearrangement including the PRP31 premessenger ribonucleic acid processing factor 31 homolog gene in family RP24. **A**: Schematic representation of the genomic region 19q13.42 in proximity to the PRP31 premessenger ribonucleic acid (pre-mRNA) processing factor 31 homolog (*PRPF31*) gene. **B**: Nested primers 91525F and PRPF31--3A2R were used to amplify the region across the deletion (the estimated size of a wild-type allele is 19,825 bp); an approximately 700 bp fragment was amplified in patient III:3, and no wild-type alleles were amplified in normal individual III:4. **C**: Allele-specific polymerase chain reaction (AS-PCR) analysis shows that the amplified products of the mutation allele (315 bp) with primers 91525F and Ins-R cosegregated with patients in this family.](mv-v19-2426-f4){#f4}

Discussion
==========

In this study, we identified one novel deletion and one novel complex genomic rearrangement in two Chinese families with adRP and characterized the breakpoints of the genomic rearrangement. To date, eight large deletions, ranging from 5 kb to 112 kb, have been identified in *PRPF31* \[[@r10]-[@r13]\]. Similar to all characterized large deletions of *PRPF31*, both breakpoints of the large deletion in family RP24 are located in the Alu regions; this suggests that the mechanism underlying this complex structural rearrangement may involve homologous recombination between Alu repeats.

Alu repeats are short, interspersed nuclear elements that account for 10% of the sequenced region of the human genome; however, these repeats account for 26.3% of chromosome 19, which is the most Alu-rich chromosome \[[@r21]\]. This is why genomic arrangements are prevalent round the *PRPF31* gene. Of the eight reported large deletions, only one is an insertion-deletion complex genomic DNA rearrangement, which includes an 110 bp deletion and a 640bp insertion \[[@r11]\]. Notably, the 640 bp insertion was also part of the *OSCAR* gene. Consistent with other reports, no additional phenotype associated with the genetic defects in the *NDUFA3*, *TFPT*, or *OSCAR* were observed in the patients of family RP24 \[[@r12],[@r13]\].

Large deletions or complex chromosome arrangements cannot be revealed with routine PCR-based DNA sequencing. Several techniques, such as RQ-PCR, multiplex ligation-dependent probe (MLPA), and comparative genomic hybridization (CGH) array, are available for detecting genomic aberrations in copy number \[[@r22]\]. A combined strategy involving different techniques applied to genomic DNA analysis could offer the most valuable option for investigating the *PRPF31* defect.

The patients of the two families in this study presented clinical features of rod-cone dystrophy in their childhood. The patients in family RP24 who carried the complex genomic DNA arrangement did not show a more severe phenotype, which is consistent with the observations of several other studies \[[@r10]-[@r13]\]. In contrast to the incomplete penetrance observed in most adRP families linked to RP11, no asymptomatic mutation/or obligate carriers were identified in family RP24. One large Chinese family carrying a 12 bp deletion was reported with high penetrance \[[@r4]\]. Compared to this high penetrance Chinese family, family RP24, which had 11 affected members, is relatively small, so incomplete penetrance cannot be formally excluded for their novel complex rearrangement.

Similar to most families harboring *PRPF31* gene mutations, an incompletely asymptomatic member was observed in family RP106. Recently, Venturini et al. identified the *CNOT3* gene as the main modifier gene for determining the penetrance of *PRPF31* mutations with a mechanism involving transcriptional repression \[[@r17]\]. The researchers found that the C allele of SNP [rs4806718](http://www.ncbi.nlm.nih.gov/snp/?term=rs4806718) in the intronic region of the *CNOT3* gene was associated with the affected status while the T allele was associated with asymptomatic status \[[@r17]\]. Our genotype results for [rs4806718](http://www.ncbi.nlm.nih.gov/snp/?term=rs4806718) did not show this kind of association. This may be due to ethnic differences, and further study is needed for confirmation. In conclusion, this study presents two deletions that further support the concept that haploinsufficiency is the main mechanism for RP11 and that genomic arrangements may be prevalent in *PRPF31* mutations.
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